Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1 2Phase 1/2 1

Status

Active not recruiting 2Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 618Head and Neck Neoplasms 598Nasopharyngeal Carcinoma 230Thyroid Neoplasms 148Oropharyngeal Neoplasms 104Carcinoma, Squamous Cell 89Salivary Gland Neoplasms 88Mouth Neoplasms 87Nasopharyngeal Neoplasms 79Recurrence 66Carcinoma, Non-Small-Cell Lung 65Laryngeal Neoplasms 60Neoplasm Metastasis 58Neoplasms 49Hypopharyngeal Neoplasms 45Thyroid Carcinoma, Anaplastic 42Thyroid Cancer, Papillary 42Melanoma 38Breast Neoplasms 36Lung Neoplasms 33Adenocarcinoma, Follicular 33Carcinoma 32Tongue Neoplasms 30Sarcoma 29Uterine Cervical Neoplasms 28Stomatitis 28Colorectal Neoplasms 28Carcinoma, Medullary 24Ovarian Neoplasms 23Esophageal Neoplasms 23

Interventions

Metformin 2Specimen Handling 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Erythroplasia × Head & Neck × Clear all
NCT05237960 2026-04-20

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

University of Arizona

Phase 2 Active not recruiting
34 enrolled
Head & Neck

Erythroplasia, Leukoplakia, Oral

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

National Cancer Institute (NCI)

Phase 2 Active not recruiting
26 enrolled 10 charts
Head & Neck

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT03990636 2019-06-19

PDTMALAC

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
40 enrolled
Head & Neck

Actinic cheilitis, Erythroplasia, Leukoplakia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡